Figure 1

![Figure 1: PRISMA flow diagram details the systematic literature search and screening process for studies evaluating platelet-rich plasma (PRP) in immune-mediated alopecias. The selection criteria yielded a defined set of eligible clinical studies.]()

> Source: Kasama Tejapira et al. "Platelet-rich plasma in alopecia areata and primary cicatricial alopecias: A sys." *Frontiers in medicine*, 2022. PMID: [36507528](https://pubmed.ncbi.nlm.nih.gov/36507528/)

<figure>
  <img src="" alt="PRISMA flow diagram details the systematic literature search and screening process for studies evaluating platelet-rich plasma (PRP) in immune-mediated alopecias. The selection criteria yielded a defined set of eligible clinical studies." />
  <figcaption>Figure 1. PRISMA flow diagram details the systematic literature search and screening process for studies evaluating platelet-rich plasma (PRP) in immune-mediated alopecias. The selection criteria yielded a defined set of eligible clinical studies.<br>  Source: Kasama Tejapira et al. "Platelet-rich plasma in alopecia areata and primary cicatricial alopecias: A sys." <em>Frontiers in medicine</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36507528/">36507528</a></figcaption>
</figure>